Gateway Investment Advisers’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Buy
7,931
+216
+3% +$104K 0.04% 201
2026
Q1
$3.79M Sell
7,715
-19,371
-72% -$10.5M 0.04% 190
2025
Q4
$15.7M Sell
27,086
-226
-0.8% -$128K 0.15% 111
2025
Q3
$13.2M Buy
27,312
+822
+3% +$383K 0.13% 116
2025
Q2
$10.7M Sell
26,490
-1,087
-4% -$454K 0.12% 128
2025
Q1
$13.7M Sell
27,577
-50,320
-65% -$27.3M 0.16% 114
2024
Q4
$40.5M Buy
77,897
+1,027
+1% +$565K 0.45% 56
2024
Q3
$47.5M Sell
76,870
-24,072
-24% -$14.2M 0.52% 49
2024
Q2
$55.8M Sell
100,942
-7,290
-7% -$4.18M 0.63% 34
2024
Q1
$62.9M Sell
108,232
-10,564
-9% -$5.93M 0.72% 27
2023
Q4
$63.1M Buy
118,796
+4,602
+4% +$2.23M 0.74% 27
2023
Q3
$57.8M Sell
114,194
-28,107
-20% -$15M 0.73% 29
2023
Q2
$74.2M Buy
142,301
+14,727
+12% +$7.95M 0.87% 21
2023
Q1
$73.5M Buy
127,574
+6,977
+6% +$3.93M 0.9% 22
2022
Q4
$66.4M Sell
120,597
-10,866
-8% -$5.76M 0.82% 29
2022
Q3
$66.7M Sell
131,463
-8,374
-6% -$4.69M 0.83% 25
2022
Q2
$76M Buy
139,837
+16,687
+14% +$9.18M 0.86% 24
2022
Q1
$72.7M Buy
123,150
+1,148
+0.9% +$659K 0.72% 29
2021
Q4
$81.4M Buy
122,002
+207
+0.2% +$129K 0.78% 27
2021
Q3
$69.6M Sell
121,795
-221
-0.2% -$121K 0.73% 29
2021
Q2
$61.6M Sell
122,016
-386
-0.3% -$182K 0.63% 37
2021
Q1
$55.9M Sell
122,402
-29,890
-20% -$14.3M 0.6% 41
2020
Q4
$70.9M Sell
152,292
-5,369
-3% -$2.52M 0.78% 28
2020
Q3
$69.6M Buy
157,661
+125,309
+387% +$51.8M 0.81% 31
2020
Q2
$11.7M Sell
32,352
-1,790
-5% -$600K 0.14% 138
2020
Q1
$9.68M Buy
34,142
+3,726
+12% +$1.17M 0.12% 150
2019
Q4
$9.88M Buy
30,416
+2,350
+8% +$713K 0.1% 185
2019
Q3
$8.18M Sell
28,066
-10,080
-26% -$2.89M 0.08% 206
2019
Q2
$11.2M Buy
38,146
+11,928
+45% +$3.29M 0.1% 180
2019
Q1
$7.18M Buy
26,218
+7,236
+38% +$1.8M 0.06% 224
2018
Q4
$4.25M Sell
18,982
-524
-3% -$123K 0.04% 290
2018
Q3
$4.76M Sell
19,506
-513
-3% -$118K 0.04% 283
2018
Q2
$4.15M Sell
20,019
-2,067
-9% -$439K 0.04% 292
2018
Q1
$4.56M Sell
22,086
-1,967
-8% -$413K 0.04% 288
2017
Q4
$4.57M Sell
24,053
-2,409
-9% -$461K 0.04% 296
2017
Q3
$5.01M Sell
26,462
-287
-1% -$52K 0.04% 279
2017
Q2
$4.67M Sell
26,749
-100
-0.4% -$16.8K 0.04% 282
2017
Q1
$4.12M Sell
26,849
-2,839
-10% -$434K 0.04% 287
2016
Q4
$4.19M Sell
29,688
-1,299
-4% -$192K 0.04% 282
2016
Q3
$4.93M Sell
30,987
-488
-2% -$75.2K 0.04% 267
2016
Q2
$4.65M Sell
31,475
-73
-0.2% -$10.8K 0.04% 277
2016
Q1
$4.47M Sell
31,548
-13,122
-29% -$1.76M 0.04% 268
2015
Q4
$6.34M Sell
44,670
-54
-0.1% -$7.2K 0.05% 249
2015
Q3
$5.47M Sell
44,724
-2,173
-5% -$283K 0.05% 258
2015
Q2
$6.08M Sell
46,897
-799
-2% -$104K 0.05% 247
2015
Q1
$6.41M Buy
47,696
+148
+0.3% +$19.1K 0.05% 247
2014
Q4
$5.96M Sell
47,548
-4,011
-8% -$488K 0.05% 255
2014
Q3
$6.28M Buy
51,559
+534
+1% +$64.9K 0.05% 262
2014
Q2
$6.02M Buy
51,025
+7,446
+17% +$876K 0.05% 268
2014
Q1
$5.24M Buy
43,579
+5,630
+15% +$669K 0.04% 271
2013
Q4
$4.23M Sell
37,949
-150
-0.4% -$14.9K 0.03% 292
2013
Q3
$3.51M Buy
38,099
+1,611
+4% +$146K 0.03% 305
2013
Q2
$3.09M Buy
+36,488
New +$3.04M 0.03% 314

Other funds holding TMO

Gateway Investment Advisers's TMO Position: Q2 2026 in Review

Gateway Investment Advisers increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $104K and bringing the position to 7,931 shares worth $3.98M. The position accounts for 0.04% of the portfolio, ranked #201.

Gateway Investment Advisers first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $81.4M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Gateway Investment Advisers held 7,931 shares of Thermo Fisher Scientific worth $3.98M as of Q2 2026.
  • Gateway Investment Advisers bought 216 Thermo Fisher Scientific shares in Q2 2026, an estimated $104K.
  • Thermo Fisher Scientific made up 0.04% of Gateway Investment Advisers's portfolio in Q2 2026, its #201 holding.
  • Gateway Investment Advisers first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Gateway Investment Advisers's Thermo Fisher Scientific position peaked at $81.4M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Gateway Investment Advisers's 13F filing for Q2 2026, filed 20 Jul 2026.